CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 145 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,000 | 0.0% | 358 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -60.0% | 358 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | +150.0% | 358 | -0.6% | 0.00% | – |
Q4 2018 | $2,000 | -50.0% | 360 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 360 | +20.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | -75.0% | 300 | -82.7% | 0.00% | – |
Q4 2017 | $16,000 | +14.3% | 1,735 | 0.0% | 0.00% | – |
Q3 2017 | $14,000 | -62.2% | 1,735 | -73.0% | 0.00% | – |
Q2 2017 | $37,000 | +32.1% | 6,435 | 0.0% | 0.00% | – |
Q1 2017 | $28,000 | +1300.0% | 6,435 | +348.4% | 0.00% | – |
Q4 2016 | $2,000 | – | 1,435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |